Asthma Clinical Trials

63 studies are recruiting for asthma in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Boston, Massachusetts 9 Dallas, Texas 9 Miami, Florida 9 New York, New York 8 Oklahoma City, Oklahoma 8 Aurora, Colorado 7 Cincinnati, Ohio 7 Houston, Texas 7 Kansas City, Kansas 7 The Bronx, New York 7 Toledo, Ohio 7 McKinney, Texas 6 Pittsburgh, Pennsylvania 6 St Louis, Missouri 6 Tampa, Florida 6 Austin, Texas 5 Colorado Springs, Colorado 5 El Paso, Texas 5 Long Beach, California 5 Newport Beach, California 5 Rock Hill, South Carolina 5 Ann Arbor, Michigan 4 Charlotte, North Carolina 4 Cleveland, Ohio 4 Columbia, Missouri 4 DuBois, Pennsylvania 4 Huntington Beach, California 4 Little Rock, Arkansas 4 Owensboro, Kentucky 4 San Antonio, Texas 4 San Jose, California 4 Asheville, North Carolina 3 Bakersfield, California 3 Bellingham, Washington 3 Birmingham, Alabama 3 Chapel Hill, North Carolina 3 Chicago, Illinois 3 Columbus, Georgia 3 Denver, Colorado 3 Detroit, Michigan 3 Durham, North Carolina 3 Indianapolis, Indiana 3 Kerrville, Texas 3 Los Angeles, California 3 Madison, Wisconsin 3 Miami Lakes, Florida 3 Missoula, Montana 3 Mobile, Alabama 3 Nashville, Tennessee 3 New Brunswick, New Jersey 3 Northfield, New Jersey 3 Northridge, California 3 Omaha, Nebraska 3 Orlando, Florida 3 Philadelphia, Pennsylvania 3 Phoenix, Arizona 3 Portland, Oregon 3 Research Triangle Park, North Carolina 3 San Diego, California 3 San Francisco, California 3

Studies, page 3

  1. Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

    The main purpose of this Phase 2 double blind, placebo controlled crossover clinical study is to demonstrate the efficacy and safety of CXA-10 in obese adult asthmatics. Obesity induces a chronic systemic inflammatory state characterized by impaired adipokine signaling, pro-inflammatory cytokine re…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT03762395 on ClinicalTrials.gov

  2. Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes

    Patients with obese late onset (after childhood) asthma can have lower FeNO levels, yet be highly symptomatic and poorly responsive to inhaled steroids. This is a common asthma phenotype, particularly among females. This reduction of NO occurs through increased arginase activity and uncoupling of N…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Duke University (Asthma, Allergy and Airway Center), Durham, North Carolina
    Run by
    University of Colorado, Denver

    See if you can join NCT03885245 on ClinicalTrials.gov

  3. Viral Infection in Asthma (VIA) Study

    Often when people with asthma get a virus caused by the common cold (rhinovirus), they also experience an increase or worsening of their asthma symptoms. The purpose of this study is to see if the study medication dupilumab helps prevent those with mild to moderate asthma from having increased asth…

    Stage
    Phase 4
    Ages
    18 to 40
    Site
    University of Virginia, Charlottesville, Virginia
    Run by
    University of Virginia

    See if you can join NCT04380038 on ClinicalTrials.gov

  4. Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

    The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung…

    Stage
    Not phased
    Ages
    6 to 16
    Site
    Indiana University, Indianapolis, Indiana
    Locations
    2 in total
    Run by
    Oregon Health and Science University

    See if you can join NCT06106646 on ClinicalTrials.gov

  5. Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma

    The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.

    Stage
    Not phased
    Ages
    18 to 99
    Site
    OUHSC, Oklahoma City, Oklahoma
    Run by
    University of Oklahoma

    See if you can join NCT02241265 on ClinicalTrials.gov

  6. Viral Mucosal Reprogramming

    This is a mechanistic, controlled, open-label, single-site study to evaluate the effects of RG-RV16 inoculation on airway mucosal gene expression and airway remodeling in 25 healthy controls (HC), in 25 allergic rhinitis subjects (AR) with cat dander allergy, and in 25 allergic asthmatic subjects (…

    Stage
    Phase 2
    Ages
    18 to 60
    Site
    University of Texas Medical Branch, Galveston, Texas
    Run by
    The University of Texas Medical Branch, Galveston

    See if you can join NCT05331170 on ClinicalTrials.gov

  7. Innate Immunity in Allergic Asthma

    The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprise…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Central Florida, Orlando, Florida
    Run by
    University of Central Florida

    See if you can join NCT06068335 on ClinicalTrials.gov

  8. Nutrition for Asthmatics

    Determine to what extent three distinct dietary approaches improve asthma control and lung function.

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Pennington Biomedical Research Center, Baton Rouge, Louisiana
    Run by
    Pennington Biomedical Research Center

    See if you can join NCT06151405 on ClinicalTrials.gov

  9. Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

    The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent expiratory airflow obstruction. Treatment will include inhaled corticosteroids and long acting beta2a…

    Stage
    Not phased
    Ages
    10 to 95
    Site
    Arthur F Gelb Medical Corporation, Lakewood, California
    Run by
    Gelb, Arthur F., M.D.

    See if you can join NCT00576069 on ClinicalTrials.gov

  10. Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

    The purpose of this study is to evaluate the site and mechanisms responsible for expiratory airflow limitation in chronic, treated, non-smoking, stable asthmatics with moderate to severe persistent expiratory airflow obstruction. Treatment will include inhaled corticosteroids and long acting beta2a…

    Stage
    Phase 4
    Ages
    10 to 80
    Site
    Arthur F Gelb Medical Corporation, Lakewood, California
    Run by
    Gelb, Arthur F., M.D.

    See if you can join NCT01225913 on ClinicalTrials.gov

  11. Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation

    Service men and women returning from deployment are significantly more likely to develop asthma and severe respiratory symptoms from airway obstruction. Why this happens is not well known, but exposure to diesel, burn pits, biomass smoke, and sandstorms are thought to play a role. Ultimately, patie…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    National Jewish Health, Denver, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT05259904 on ClinicalTrials.gov

  12. Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

    The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial …

    Stage
    Not phased
    Ages
    18 to 65
    Site
    University of Colorado, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT03215836 on ClinicalTrials.gov

  13. Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

    Reslizumab is a type of medicine called a monoclonal antibody that is made in the research clinic; it works by blocking a specific protein in the body called interleukin-5. The study medicine, reslizumab, is not yet approved for doctors to treat patients with EGPA. It is considered an experimental …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    National Jewish Health, Denver, Colorado
    Run by
    National Jewish Health

    See if you can join NCT02947945 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.